Clinical Trials in the Category "Glioblastoma"
Drug Intervention Trials that are Recruiting
Study Title |
Principal Investigator | Disease Category | |
 |
|||
| Phase 2 of Azixa™ (MPC-6827) for Glioblastoma Multiforme in First or Second Relapse |
Dr Lawrence Recht |
Brain Cancer
Glioblastoma | |
|
|||
| BIBW 2992 With or Without Daily Temozolomide For Recurrent Malignant Glioma |
Dr Lawrence Recht |
Oligodendroglioma
Glioma Glioblastoma | |
|
|||
Trials not Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
|
Phase II/III Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III)
(No longer recruiting) |
Dr Lawrence Recht |
Central Nervous System Neoplasms
Brain Cancer Glioblastoma | |
|
|||
| The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials. |
Trial Administration